II. Uterine fibroid embolization: Technical aspects

Techniques in Vascular and Interventional Radiology

Volumn 5, Issue 1, 2002, Pages 17-34

  Worthington Kirsch, Robert L ^a   Andrews, Robert T ^a   Siskin, Gary P ^a   Shlansky Goldberg, Richard ^a   Lipman, John C ^a   Goodwin, Scott C ^a   Bonn, Joseph ^a   Hovsepian, David M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CEFAZOLIN; GELFOAM; GLYCERYL TRINITRATE; HEPARIN; KETOROLAC; LIDOCAINE; MICROSPHERE; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; POLYVINYL ALCOHOL;

ARTERY CATHETERIZATION; ARTICLE; FLUOROSCOPY; GUIDE WIRE; HUMAN; OVARY; PELVIS; RADIATION ABSORPTION; RADIATION EXPOSURE; UTERINE ARTERY; UTERINE ARTERY EMBOLIZATION; UTERUS;

EID: 0036315018     PISSN: 10892516     EISSN: None     Source Type: Journal    
DOI: 10.1053/tvir.2002.124101     Document Type: Article

References (65)

1. Uterine artery anatomy relevant to uterine leiomyomata embolization
2. Arterial anatomy of the female genital tract: Variations and relevance to transcatheter embolization of the uterus
3. Anatomic variations in the uterine arteries: A cause of failure of uterine artery embolisation for the management of symptomatic fibroids
4. Obstetric embolotherapy: Effect on menses and pregnancy
5. Pregnancy after bilateral ligation of the internal iliac and ovarian arteries
6. Full-term deliveries after ligation on bilateral internal iliac arteries and infundibuopelvic ligaments
7. Uterine artery embolization: Reduced radiation with refined technique
8. Surgical complications of transaxillary arteriography: A case-control study
9. Technique for left gastric artery catheterization
10. The loop catheter technic
11. A new twist on the Waltman loop for uterine fibroid embolization
12. Uterine arterial embolization: Factors influencing patient radiation exposure
13. Embolic agents used for uterine fibroid embolization
14. Longterm histopathologic follow-up of bronchial arteries after therapeutic embolization with polyvinyl alcohol (Ivalon) in patients with cystic fibrosis
15. Experimental observations on short and long-term effects of arterial occlusion with Ivalon
16. Histologic long-term follow-up after embolization with polyvinyl alcohol particles
17. Histopathologic appearance of arterial occlusions with hydrogel and polyvinyl alcohol embolic material in domestic swine
18. Efficacy of trisacryl gelatin microspheres versus polyvinyl alcohol particles in the preoperative embolization of meningiomas
19. Calibrated sphere embolization of craniofacial tumors and arteriovenous malformations
20. Trisacryl gelatin microspheres for therapeutic embolization, II: Preliminary clinical evaluation in tumors and arteriovenous malformations
21. Initial experience with use of tris-acryl gelatin microspheres for uterine artery embolization for leiomyomata
22. Uterine artery embolization: An underused method of controlling pelvic hemorrhage
23. Transcatheter occlusion of abdominal tumors
24. Long term follow-up of transcatheter embolization with autologous clot, oxycel and gelfoam in domestic swine
25. Surgical investigation of new absorbable sponge derived from gelatin for use in hemostasis
26. Gelfoam embolization of the left gastric artery for bleeding ulcer: Experimental considerations
27. Uterine artery embolisation of myomas: Preliminary results of gelatin sponge pledgets as the embolic agent
28. Uterine artery embolization for the treatment of uterine leiomyomata midterm results
29. Arterial embolization of uterine myoma: Results apropos of 286 cases
30. Uterine artery embolization for leiomyomata
31. Uterine fibroid embolization: Nonsurgical treatment for symptomatic fibroids
32. Use of an absorbable embolic material for arterial embolization for uterine leiomyomas: Midterm results on symptoms and volume of leiomyomas
33. Uterine artery embolisation for symptomatic fibroids: Experience of a cost-effect approach in a developing country using gelfoam only
34. Uterine artery embolization with gelatin sponge particles alone for symptomatic uterine fibroids
35. An experimental study of embolic effect according to infusion rate and concentration of suspension in transarterial particulate embolization
36. A method to prepare polyvinyl alcohol particles in order to optimize particle suspension prior to intravascular administration
37. Polyvinyl alcohol particle size and suspension characteristics
38. Trisacryl gelatin microspheres for therapeutic embolization, I: Development and in vitro evaluation
39. Uterine fibroid embolization: Choice of an embolic particle
40. Pregnancy following uterine fibroid embolization
41. Pregnancy after embolization of uterine myoma: Report of 12 cases
42. Uterine artery embolization for symptomatic uterine myomas
43. Noncoronary angioplasty
44. Effects of diltiazem and nifedipine on systemic and coronary hemodynamics and ischemic responses during transient coronary artery occlusion in patients
45. Effects of nitroglycerin and nifedipine on coronary and systemic hemodynamics during transient coronary artery occlusion
46. Preliminary experience with uterine artery embolization for uterine fibroids
47. Intraarterial lidocaine for pain control after uterine artery embolization for leiomyomata
48. Fibroid-related menorrhagia: Treatment with superselective embolization of the uterine arteries and midterm follow-up
49. Bilateral uterine artery embolisation for leiomyomata: Results, complications and failures
50. Polyvinyl alcohol particle size for uterine artery embolization
51. Flow redistribution during uterine artery embolization for the management of symptomatic fibroids
52. Hepatic arterial redistribution for intra-arterial infusion of neoplasms
53. Utility of nonselective abdominal aortography in demonstrating ovarian artery collaterals in patients undergoing uterine artery embolization for fibroids
54. Radiogenic cancer at specific sites
55. Genetic effects of radiation
56. The ovary
57. Potential biological effects following high X-ray dose interventional procedures
58. Management of patient skin dose in fluoroscopically guided interventional procedures
59. Radiation safety considerations for diagnostic radiology personnel
60. Influence of radiographic technique and equipment on absorbed ovarian dose associated with uterine artery embolization